CORE ONE LABS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.235 CAD | +17.50% |
|
+14.63% | -18.97% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -18.97% | 6.68M | |
| +40.86% | 6.16B | |
| -16.30% | 4.49B | |
| -9.93% | 3.17B | |
| -1.58% | 3.01B | |
| -1.70% | 2.57B | |
| +37.23% | 1.8B | |
| -12.78% | 1.62B | |
| +1.02% | 1.56B | |
| -12.97% | 1.53B |
- Stock Market
- Equities
- COOL Stock
- News Core One Labs Inc.
- Core One Labs' ' Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies
